Showing 15 posts of 283 posts found.


Australia pauses AstraZeneca vaccine for people under 60

June 18, 2021
Medical Communications AstraZeneca, Australia, COVID-19, Vaccine

Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …

G7: UK to donate 100 million surplus vaccine doses

June 11, 2021
Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine

Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …


Pfizer to expand COVID vaccine study in children under 12

June 10, 2021
COVID-19, Pfizer, Vaccine

Pfizer has announced that it will begin large-scale testing of its COVID-19 vaccine after selecting a lower dose of the …


Vaccine patch outperforms needle-and-syringe jabs in pre-clinical study

June 3, 2021
COVID-19, Vaccine, technology

Vaxxas, an Australian clinical-stage biotechnology company, has announced positive results from pre-clinical trials into its novel high-density microarray patch (HD-MAP) …

Australian study sees 70% HPV reduction in gay and bisexual men

May 26, 2021
Research and Development Australia, HPV, Vaccine

A school-based human papillomavirus (HPV) vaccination study programme, led by Monash University and Alfred Health, found a 70% reduction in …


Takeda: Dengue vaccine successful in long-term trials & set for global distribution

May 25, 2021
Manufacturing and Production EMA, Vaccine, dengue

Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …

Australian PM calls for domestic mRNA vaccine production

May 21, 2021
Medical Communications Australia, Moderna, Vaccine, mrna

Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …


Japan approves Moderna & AstraZeneca COVID-19 vaccines

May 21, 2021
Medical Communications COVID-19, Japan, Vaccine

A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …


FDA authorizes use of Pfizer vaccine for children aged 12-15

May 11, 2021
Manufacturing and Production COVID-19, FDA, Pfizer, Vaccine

The FDA announced it has expanded the emergency use of the Pfizer-BioNTech vaccine in children aged 12-15 yesterday.It was determined …

Canada first country to authorise Pfizer vaccine in children aged 12-15

May 6, 2021
COVID-19, Canada, Pfizer, Vaccine

Canada has become the first country to authorise the use of Pfizer’s COVID-19 vaccine for children aged between 12 and …

UK government to invest £29.3 million on COVID-19 variant testing

May 5, 2021
Research and Development COVID-19, UK government, Vaccine, variants

The UK government has announced an investment of £29.3 million, on top of the £19.7 million already pledged, to be …


Moderna to supply up to 500 million COVID-19 vaccines to COVAX

May 4, 2021
Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …


Moderna up investments to produce 3 billion COVID vaccine doses in 2022

April 29, 2021
COVID-19, Moderna, Vaccine, investment

Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …

COVID Symptom Study app reveals most common vaccine side effects

April 28, 2021
Research and Development COVID-19, Vaccine, data

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …

Single dose of COVID vaccine can cut transmissions in half

April 28, 2021
Research and Development COVID-19, Public Health England, Vaccine

A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …

Latest content